申请人:Carter-Wallace, Inc.
公开号:US04224323A1
公开(公告)日:1980-09-23
A method for lowering serum uric acid is disclosed which comprises administering to a human for its uricosuric activity a pharmaceutical composition comprising 7-chloro-2-methyl-3,3a-dihydro-2H,9H-isoxazolo (3,2-b) (1,3)-benzoxazin-9-one. 7-chloro-2-methyl-3,3a-dihydro-2H,9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one is a useful compound having valuable pharmacological properties, for example, it is a valuable anti-inflammatory agent, as evidenced by its ability to inhibit the local edema formation characteristic of inflammatory states when administered systemically to warm-blooded animals.
公开了一种降低血清尿酸的方法,包括向人体给予含有7-氯-2-甲基-3,3a-二氢-2H,9H-异噁唑啉(3,2-b)(1,3)-苯并噁唑啉-9-酮的药物组成物,以发挥其利尿作用。7-氯-2-甲基-3,3a-二氢-2H,9H-异噁唑啉(3,2-b)(1,3)-苯并噁唑啉-9-酮是一种有价值的化合物,具有有价值的药理学特性,例如,它是一种有价值的抗炎药物,通过其系统给予温血动物时,它能够抑制炎症状态下局部水肿形成的特征。